Receipt of Kazakh regulatory approval

Summary by AI BETAClose X

Central Asia Metals PLC has received regulatory approval from Kazakhstan for the issuance of new shares related to its proposed all-share acquisition of Cygnus Metals Limited. The company anticipates that remaining conditions precedent will be met before the Second Court Hearing on October 14, 2026, with the acquisition expected to become effective on October 15, 2026, and completion on October 27, 2026.

Disclaimer*

Central Asia Metals PLC
13 October 2026
 

A white background with blue text

Description automatically generated

13 October 2026

Central Asia Metals PLC

(the ‘Company’ or ‘CAML’)

Receipt of Kazakh regulatory approval for the proposed acquisition of Cygnus Metals

Central Asia Metals PLC (AIM: CAML) issues a further update regarding the proposed acquisition of Cygnus Metals Limited (ASX:CY5, TSXV: CYG, OTCQB: CYGGF) (‘Cygnus’) by means of an Australian Scheme of Arrangement (the ‘Scheme’) as announced on 2 June 2026 (the ‘Cygnus Transaction’). Under the Scheme, CAML will acquire 100% of Cygnus in an all-share transaction.

CAML is pleased to announce receipt of approval from the relevant authorities in Kazakhstan for the issue of the New CAML shares pursuant to the Scheme, which was a condition precedent to the Scheme. Cygnus has advised CAML that it anticipates that the remaining conditions precedent to the Scheme will be satisfied or waived (as applicable) at or immediately prior to the Second Court Hearing.

The Second Court Hearing remains scheduled to take place at 14:15 (AWST[1]) on 14 October 2026. The indicative timetable for completion of the Cygnus Transaction is unchanged from that detailed in CAML’s announcement of 23 September 2026: an Effective Date of 15 October 2026, with the Implementation Date following on 27 October 2026[2].

For further information contact:

Central Asia Metals

Tel: +44 (0) 20 7898 9001

Gavin Ferrar

 

CEO

 

Louise Wrathall

 

CFO

 

Richard Morgan

richard.morgan@centralasiametals.com

Investor Relations Manager

 

Peel Hunt (Nominated Adviser and joint broker)

Tel: +44 (0) 20 7418 8900

Ross Allister

 

David McKeown

 

Emily Bhasin

 

BMO Capital Markets (joint broker)

Tel: +44 (0) 20 7236 1010

Thomas Rider

 

Pascal Lussier Duquette

 

BlytheRay (PR advisers)

Tel: +44 (0) 20 7138 3204

Megan Ray

CentralAsiaMetals@BlytheRay.com

Rachael Brooks

 

Note to editors:

Central Asia Metals, an AIM-quoted UK company based in London, owns 100% of the Kounrad SX-EW copper operation in central Kazakhstan and 100% of the Sasa zinc-lead mine in North Macedonia. The Company also owns an 80% interest in CAML Exploration and 100% in CAML XD, two subsidiaries formed to progress early-stage exploration opportunities in Kazakhstan, and a 38.9% interest in Aberdeen Minerals Ltd, a privately-owned UK company focused on the exploration and development of base metals opportunities in northeast Scotland.

For further information, please visit www.centralasiametals.com and follow CAML on X at @CamlMetals and on LinkedIn at Central Asia Metals Plc

 

A close up of a logo

Description automatically generated


[1] Australian Western Standard Time

[2] Note: all of the above times and dates are indicative only. The actual timetable will depend on many factors outside the control of CAML and Cygnus, including the Court approval process and the satisfaction (or waiver) of the conditions precedent to the completion of the Scheme. Owing to the time zone differences between Canada and Australia, certain actions relating to the implementation of the Scheme may occur on 26 October 2026 during Canadian business hours to enable implementation to occur on 27 October 2026.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings